Stay updated on SubQ Efgartigimod in CIDP Clinical Trial
Sign up to get notified when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.

Latest updates to the SubQ Efgartigimod in CIDP Clinical Trial page
- Check5 days agoChange DetectedVersion updated to v3.0.2 with a Back to Top link added. The legacy v3.0.0-post.1 tag was removed.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated to a new version, specifically from v3.0.0 to v3.0.0-post.1-g752effb-HEAD.SummaryDifference0.0%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location details, as well as a comprehensive list of publications related to chronic inflammatory demyelinating polyradiculoneuropathy. Additionally, several outdated location entries have been removed.SummaryDifference10%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check41 days agoChange DetectedThe web page has been updated from version v2.16.8 to v2.16.11, indicating a revision in the content.SummaryDifference0.0%
- Check48 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.8, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
Stay in the know with updates to SubQ Efgartigimod in CIDP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.